Raynaud's Phenomenon: Differential Diagnosis and Work-Up
Raynaud's phenomenon requires distinguishing between primary (idiopathic) and secondary forms, with secondary Raynaud's most commonly associated with systemic sclerosis, other connective tissue diseases, and vasculitides—this distinction fundamentally determines prognosis and treatment approach.
Differential Diagnosis
Primary vs Secondary Raynaud's Phenomenon
The critical first step is determining whether Raynaud's is primary (benign, isolated vasospasm) or secondary to an underlying systemic disease 1.
Secondary Raynaud's phenomenon is associated with:
Connective tissue diseases (most important to identify):
Vasculitides 1:
- Small vessel vasculitis (most common with Raynaud's)
- Medium vessel disease (polyarteritis nodosa, temporal arteritis)
- Thromboangiitis obliterans (Buerger's disease) - particularly in young tobacco users
Prothrombotic states 1:
- Antiphospholipid syndrome (lupus anticoagulant, anticardiolipin antibodies)
- Protein C, S, or antithrombin III deficiencies
- Factor V Leiden or prothrombin mutations
- Hyperhomocysteinemia
- Malignancy-associated hypercoagulability
Drug-induced vasospasm 2:
- Bleomycin
- Clonidine
- Ergot alkaloids
- Beta-blockers
- Cancer immunotherapy (checkpoint inhibitors) 3
Occupational/environmental:
- Vibration injury
- Cold exposure (occupational)
Other vascular diseases 1:
- Atherosclerotic disease
- Thromboembolic disease
Recommended Work-Up
Clinical Assessment
History must specifically address:
- Age of onset (primary typically <30 years; secondary often >30 years)
- Smoking history (critical for Buerger's disease)
- Medication review (especially drugs listed above)
- Occupational exposures (vibration, cold)
- Digital ulcers, pitting scars, or gangrene 2
- Systemic symptoms: skin thickening, dysphagia, dyspnea, arthralgias, dry eyes/mouth, muscle weakness
- Family history of autoimmune disease
Physical examination must include:
- Skin examination for sclerodactyly, skin thickening, telangiectasias, calcinosis
- Digital pitting scars or active ulcers
- Nail fold capillaroscopy findings (dilated/dropout capillaries suggest secondary Raynaud's)
- Peripheral pulses (assess for large vessel disease)
- Blood pressure in both arms (assess for subclavian stenosis)
- Lung auscultation (crackles suggest ILD)
- Joint examination
Laboratory Investigations
First-tier testing (all patients with suspected secondary Raynaud's):
- Antinuclear antibody (ANA) - screening test for connective tissue disease
- Complete blood count - assess for cytopenias (lupus, other CTD)
- Erythrocyte sedimentation rate/C-reactive protein - inflammatory markers
- Creatinine and urinalysis - renal involvement
Second-tier testing (if ANA positive or high clinical suspicion):
SSc-specific antibodies 2:
- Anti-centromere antibody (limited cutaneous SSc)
- Anti-Scl-70 (topoisomerase I) (diffuse cutaneous SSc, ILD risk)
- Anti-RNA polymerase III (diffuse SSc, renal crisis risk)
Other CTD antibodies:
- Anti-dsDNA, anti-Smith (lupus)
- Anti-Ro/SSA, anti-La/SSB (Sjögren's, lupus)
- Anti-RNP (mixed CTD)
- Rheumatoid factor, anti-CCP (rheumatoid arthritis)
Antiphospholipid antibodies:
- Lupus anticoagulant
- Anticardiolipin antibodies (IgG and IgM)
- Anti-beta-2-glycoprotein I
Thrombophilia panel (if thrombotic history or young patient):
- Protein C, protein S, antithrombin III
- Factor V Leiden
- Prothrombin gene mutation
- Homocysteine level
Cryoglobulins (if vasculitis suspected)
ANCA (if small/medium vessel vasculitis suspected) 3
Specialized Testing
Nailfold capillaroscopy - essential for distinguishing primary from secondary Raynaud's:
- Normal capillaries suggest primary Raynaud's
- Dilated capillaries, capillary dropout, hemorrhages suggest secondary Raynaud's (especially SSc) 2
If systemic sclerosis is suspected or confirmed 2, 4:
- Pulmonary function tests with DLCO (screen for ILD and PAH)
- High-resolution chest CT (if PFTs abnormal or high risk)
- Echocardiography (screen for PAH)
- Esophageal manometry/pH monitoring (if dysphagia)
Vascular studies (if large vessel disease suspected):
- Ankle-brachial index
- Arterial duplex ultrasound
- CT or MR angiography
Critical Pitfalls to Avoid
Do not dismiss Raynaud's in patients >30 years as "primary" - secondary causes are more likely and require investigation 1
Do not overlook drug-induced causes - particularly checkpoint inhibitors in cancer patients, which can cause new-onset Raynaud's and even scleroderma-like reactions 3
Recognize that autoantibodies may be absent - particularly in vasculitis and some cases of SSc 3, 5
Digital ulcers or tissue loss demand urgent evaluation - these indicate severe ischemia and risk of gangrene/amputation 2
"Prescleroderma" patients (isolated Raynaud's with positive SSc antibodies or abnormal capillaroscopy) require close monitoring as up to 50% develop definite CTD within years 2
Thromboangiitis obliterans (Buerger's disease) is frequently missed - consider in young smokers with distal extremity ischemia and superficial thrombophlebitis 1
Algorithmic Approach
Step 1: Clinical assessment → Age, smoking, medications, systemic symptoms, digital ulcers
Step 2: If age >30, systemic symptoms, digital ulcers, or abnormal exam → Proceed with laboratory work-up
Step 3: ANA + first-tier labs → If positive or high suspicion → SSc-specific antibodies and nailfold capillaroscopy
Step 4: If SSc suspected/confirmed → Organ screening (PFTs, HRCT, echo, BP monitoring if anti-RNAPIII positive) 2, 4
Step 5: If thrombotic history or young patient → Thrombophilia and antiphospholipid work-up
Step 6: If vasculitis features → ANCA, cryoglobulins, consider biopsy
The work-up intensity should escalate based on red flags: age >30 at onset, male gender, asymmetric symptoms, digital ulcers/tissue loss, systemic symptoms, or abnormal initial testing 1, 2, 1.